A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma |
University of California at Santa Cruz / David Haussler, PhD |
Innovation Grants |
2015 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia |
University of California San Francisco / Mignon Loh, M.D. |
Innovation Grants |
2014 |
California |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |
Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers |
University of California at Santa Cruz / Seth Rubin, PhD |
Innovation Grants |
2017 |
California |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium
|
Children’s Hospital Los Angeles / Robert Seeger, MD |
Phase I/II Infrastructure Grants |
2006 |
California |
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma |
University of California San Francisco / Ozlem Aksoy, PhD |
Young Investigator Grants |
2015 |
California |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |